Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

One-year Parent-Child Assistance Program for parents with recent substance use

Official title: Promoting Parent and Child Well-Being and Reducing the Need for Foster Care: An Evaluation of a One-Year, Home-Visiting and Case Management Program for People Using Substances

Run by University of Oklahoma · NCT06163651 · Data updated 2026-11-12

This project will test whether a one-year Parent-Child Assistance Program helps parents who used substances during pregnancy stay with or reunify with their children and support their recovery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorUniversity of Oklahoma
Academic / other
Locations2 sites (Enid, Oklahoma and 1 other locations)
StatusRecruiting
StartedJune 23, 2025
Main results expectedSeptember 29, 2026
Study endsSeptember 30, 2026
Registry record updatedJuly 3, 2025
Trial IDNCT06163651 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are parents aged 18 or older who used substances during their current or most recent pregnancy and have a child under six living with them within the Enid or Oklahoma City catchment areas.

Probably not a fit

People who are incarcerated at enrollment or who live outside the program's 50-mile catchment around Enid or Oklahoma City are not eligible and therefore unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Investigators are implementing a one-year adaptation of the Parent-Child Assistance Program (PCAP-1), an intensive home-visiting and case management intervention originally delivered over three years. Trained case managers meet biweekly with participants to coach goal-setting, provide practical and emotional support, and connect families to community recovery and social services while receiving clinical supervision. The project will measure causal effects of PCAP-1 on foster care placement, reunification rates, parent recovery outcomes, and prevention of future prenatal substance exposure using data and partnerships with state and federal agencies. Implementation focuses on parents over 18 with children under six living with them in the Enid or Oklahoma City areas.

Why it matters

Potential benefit: If successful, PCAP-1 could reduce foster care placements, increase family reunifications, and improve parental recovery and linkage to community supports.

How similar studies have gone: The original three-year PCAP model has prior evidence of improving maternal recovery and reducing child welfare involvement, but the one-year format is a novel adaptation with limited causal evidence to date.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* People over the age of 18
* Parents with children under the age of 6 living with them
* Resides within a 50-mile radius of Enid, OK or Oklahoma City, OK (for treatment group)

Exclusion Criteria:

\- Incarcerated at the time of enrollment

Where it's running

  • Remote Worker
    Enid, Oklahoma, United States
    Recruiting
  • Remote Worker
    Oklahoma City, Oklahoma, United States
    Recruiting

Study contacts

  • Principal investigator: Julie Gerlinger, PhD — University of Oklahoma
  • Study coordinator: Julie Gerlinger, PhD
  • Email: jgerlinger@ou.edu
  • Phone: 405-325-1751

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.